Skip to content

Mads Emil Bjørn

  • Mr
  • 6h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 101CitationsNumber of citations received by Mads Emil's publications. Updated daily.

Other IDs

Research interests

Myeloproliferative neoplasia

Co-authors (47)

Publications (5)

  • Reduced glutathione as a physiological co-activator in the activation of peptidylarginine deiminase

    • Damgaard D
    • Bjørn M
    • Steffensen M
    • et al.
    N/AReaders
    9Citations
    Get full text
  • Corrigendum to "Combination therapy with interferon and JAK1-2 inhibitor is feasible. Proof of concept with rapid reduction in JAK2V617F-allele burden in Polycythemia Vera" [Leuk. Res. Rep. 3 (2) (2014) 73-75]

    • Bjørn M
    • de Stricker K
    • Kjær L
    • et al.
    N/AReaders
    0Citations
    Get full text
  • Telomerase inhibitor imetelstat in essential thrombocythemia and myelofibrosis

    • El Fassi D
    • Bjørn M
    • Nielsen C
    • et al.
    N/AReaders
    0Citations
    Get full text
  • Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat

    • Andersen C
    • Bjørn M
    • McMullin M
    • et al.
    N/AReaders
    5Citations
    Get full text
  • Combination therapy with interferon and JAK1-2 inhibitor is feasible: Proof of concept with rapid reduction in JAK2V617F-allele burden in polycythemia vera

    • Bjørn M
    • de Stricker K
    • Kjær L
    • et al.
    N/AReaders
    19Citations
    Get full text